Navigation Links
In Focus with Martin Sheen Showcasing How Medication is Helping Win the Fight Against Mood Disorders
Date:3/12/2013

Hollywood, CA (PRWEB) March 12, 2013

The producers of In Focus with Martin Sheen are pleased to announce a new report showcasing how people battling mood disorders are receiving new hope through advanced medications.

In Focus Martin Sheen PBS is an independently produced television series airing in markets around the country on public television. The program is hosted by the legendary Martin Sheen, who is about to embark on his second half-century in American entertainment. Mr. Sheen has developed a reputation as one of Hollywood’s most respected actors during a career that includes more than 60 film appearances.

In Focus Martin Sheen is looking at the innovations in healthcare that are making a difference in the lives of patients, and for the millions of Americans dealing with some form of mood disorder, new medications are helping people lead healthy, happy lives.

In this new report, In Focus will be talking to mental health experts about how these new medications work to achieve the right chemistry in the brain to help people overcome mood disorders. Coupled with therapy, these medications are helping people live lives free from the suffering of many serious conditions like depression or bipolar disorder.

The producers of In Focus with Martin Sheen are hoping to debut the new report in May. Viewers can find air times and dates by checking their local listings. For more information about the reports or to offer other ideas related to this topic, In Focus with Martin Sheen can be reached through the show’s official website at infocusptv.com or on Facebook at facebook.com/InFocusMartinSheen.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10521984.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
2. Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient Response
3. Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research
4. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
5. Vermillion Sharpens Focus and Streamlines Operations in 2012
6. Inverseon Focuses on Mucous and Smoking Cessation
7. First Statewide Biotech Meeting Focuses on Patient Access, Innovation
8. Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
9. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
10. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
11. All the colors of a high-energy rainbow, in a tightly focused beam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):